Skip to main content

Table 1 Demographic, clinical parameters and outcomes of patients with anti-GBM disease

From: The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease

  n=46
Age (years) 35.3±15.7
Gender (male/female) 32/14
Hydrocarbon exposure, n (%) 3/44 (6.8%)
Prodromal infection, n (%) 19/46 (41.3%)
Smoking, n (%) 24/45 (53.3%)
Hemoptysis, n (%) 15/46 (32.6%)
Oliguria/anuria, n (%) 14/46 (30.4%)
Gross hematuria, n (%) 15/31 (32.6%)
Nephrotic syndrome, n (%) 19/31 (61.3%)
Serum creatinine at presentation (μmol/L) 728.5±378.8
Level of anti-GBM antibodies (U/mL) median (range) 63 (15, 176)
Positive with ANCA, n (%) 9/46 (19.6%)
Hemoglobin (g/L) 85.6±26.1
Percentage of crescents in glomeruli (%) 78.8±29.6
Cellular crescents (%) 60.3±33.8
Fibrotic crescents (%) 33.2±31.0
Renal survival (1 year), n (%) 10/46 (21.7%)
Patient survival (1 year), n (%) 36/46 (78.3%)
  1. GBM: glomerular basement membrane; ANCA: anti-neutrophil cytoplasmic antibody.